PGNY
Progyny, Inc.
Healthcare Plans · Healthcare · United States
28.40
close · 2026-10-29
value
60
cheaper than peers60
quality
86
stronger fundamentals86
ranked against
Healthcare
value
quality
547 peerssector comparisonwide variation
Value inputs
| measure | company | vs peers |
| forward P/E | 12.28× | 75 |
| price to sales | 1.66× | 74 |
| EV to EBITDA | 15.46× | 49 |
| price to book | 4.81× | 35 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| return on equity | 16.2% | 85 |
| operating margin | 11.4% | 79 |
| debt to equity | 5.0% | 76 |
| revenue growth | 5.3% | 38 |
4 of 4 measures available
Facts
| market cap | $2B |
| free cash flow | $200.9M |
| employees | 835 |
| first trade | 2019-10-25 |
| next earnings | 2026-11-04 |
| fundamentals updated | 2026-08-10 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | 0.65 | 0.57 | 0.62 | 0.30 |
| free cash flow | $191.8M | $173.7M | $185.2M | $77.2M |
| net income | $58.5M | $54.3M | $62.0M | $30.4M |
| revenue | $1.29B | $1.17B | $1.09B | $786.9M |